Trump administration considering UK COVID-19 vaccine before election


US coronavirus catastrophe: Who is to blame? | Head to Head [48:40]
The Trump administration is considering fast-tracking an experimental COVID-19 vaccine being developed by AstraZeneca Plc and Oxford University for use in the US ahead of the November 3 elections, the Financial Times reported.
One option being explored would involve the US Food and Drug Administration (FDA) awarding "emergency use authorization" in October to the potential vaccine, which was developed by Oxford and licensed to AstraZeneca, the FT reported.





Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

Taylor Swift: 'White supremacy is repulsive. There is nothing worse'

ORIGIN OF THE AKAN - Onyeji Nnaji

GARDEN OF EDEN FOUND IN WEST AFRICA - Onyeji Nnaji

TYPES OF PREPOSITION - Onyeji Nnaji

Tulsi Gabbard says impeachment of Trump would be 'terribly divisive' for country

Marine Charged for Facebook Comments Gets Hearing Date

EGYPTIANS LAMBAST NIGERIAN FOOTBALLERS OVER ‘FREQUENT’ PROTESTS

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji